Enzon Pharmaceuticals's total assets for Q4 2024 were $47.17M, a decrease of -0.23% from the previous quarter. ENZN total liabilities were $44.16M for the fiscal quarter, a -0.79% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.